Moderna股價下跌，RSV疫苗18個月後的效力僅50%

Reported 9 months ago

Moderna股票下跌，因公司表示其新批准的RSV疫苗在18個月後僅約50%有效。Yahoo Finance的Anjalee Khemlani分析了疫苗的效力以及與競爭對手GSK和Pfizer的類似疫苗相比較。想獲得更多專家見解和最新市場動向，請點擊這裡觀看完整的Market Domination Overtime節目。

You may also interested in these wikis

DoorDash, Williams-Sonoma, and TKO Group to Join S&P 500

Brewery Offers 1,461 Beers to Help Canadians Navigate Political Turmoil

Bankers Strive to Align with EU's Defense Priorities Amid Changing Landscape

Warren Buffett Invests in Three Value Stocks Despite Market Prices

New Real Estate Commission Rules Fail to Reduce Home Buying and Selling Costs

These Stocks Are Moving the Most Today: Redfin, DoorDash, Nvidia, Tesla, MicroStrategy, Robinhood, Oracle, and More

Possible Government Shutdown Looms with 1 in 3 Odds

Planning a Retirement Budget with $1.3 Million in Savings and Social Security

China Imposes Retaliatory Tariffs on Canadian Products Amid Trade Tensions

Avantio Launches Dynamic Pricing Tool to Enhance Revenue

Back to all Wikis